ED-Finanzas

No es posible guardar favoritos sin iniciar sesión.

Usá Login / Registrar en el header (usuario + contraseña).

VNRX

VolitionRX Ltd · AMEX

Healthcare · Medical Devices · USA · Nano

0.5
-0.04 (-6.96%)
Aug 17 3:59 PM ET

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Chart

Lightweight Charts · Yahoo Finance

Date Headline URL From
Aug-14-26 08:30AM VolitionRx Limited Q2 2026 Earnings Call Summary link (Moby)
Aug-13-26 05:32PM VolitionRX: Q2 Earnings Snapshot link (Associated Press)
Aug-13-26 04:10PM VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update link (PR Newswire)
Aug-13-26 09:24AM Earnings To Watch: VolitionRX Ltd (VNRX) Q2 2026 -- GF Value Sees 3914% Upside link (GuruFocus.com)
Aug-12-26 08:17AM Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients link (PR Newswire)
Aug-11-26 04:10PM VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update link (PR Newswire)
Aug-05-26 08:17AM Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq Liquid Biopsy Technology link (PR Newswire)
Jul-30-26 08:17AM Volition Advances Nu.Q NETs Platform Towards Commercialization link (PR Newswire)
Jul-07-26 08:17AM VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q Cancer Test link (PR Newswire)
Jun-17-26 08:15AM VolitionRx Announces Collaboration with Sysmex link (PR Newswire)
Jun-07-26 06:30PM VolitionRx Announces Pricing of $4.6 Million Public Offering link (PR Newswire)
Jun-03-26 08:12AM VolitionRx Files New Patent Protecting its Nu.Q NETs Test for Ebola Triage and Treatment Monitoring link (PR Newswire)
May-27-26 08:17AM VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets link (PR Newswire)
May-15-26 07:02PM VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... link (GuruFocus.com)
May-14-26 06:32PM VolitionRX: Q1 Earnings Snapshot link (Associated Press)
May-14-26 04:10PM VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update link (PR Newswire)
May-11-26 08:19AM VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update link (PR Newswire)
May-06-26 08:17AM VolitionRx Announces Submission of Manuscript for Nu.Q Vet Cancer Test in Cats link (PR Newswire)
Apr-29-26 08:17AM Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing link (PR Newswire)
Apr-23-26 08:12AM VolitionRx Announces Acceptance of Compliance Plan by NYSE American link (PR Newswire)
Apr-20-26 07:30AM Volition Launches rNuQ Webshop Broadening Product Range link (PR Newswire)
Apr-02-26 09:01PM VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... link (GuruFocus.com)
Apr-01-26 08:30AM VolitionRx Limited Q4 2025 Earnings Call Summary link (Moby)
Mar-31-26 06:51PM VolitionRX: Q4 Earnings Snapshot link (Associated Press)
Mar-31-26 04:05PM VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update link (PR Newswire)
Mar-31-26 09:18AM VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings link (GuruFocus.com)
Mar-31-26 08:16AM VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium link (PR Newswire)
Mar-30-26 08:13AM Volition Announces Mayo Clinic Study Demonstrates Nu.Q Concentrations are Elevated in Trauma Patients link (PR Newswire)
Mar-26-26 08:17AM Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference link (PR Newswire)
Mar-25-26 04:12PM VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update link (PR Newswire)
Mar-25-26 08:17AM Volition Announces Detection of Over 95% of Early-Stage Cancers link (PR Newswire)
Mar-18-26 08:17AM Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA link (PR Newswire)
Mar-07-26 08:18AM VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems link (TipRanks)
Mar-06-26 08:10AM Volition Announces First Ever Automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems link (PR Newswire)
Feb-25-26 08:10AM VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution link (PR Newswire)
Feb-10-26 08:07AM Volition Announces the Appointment of New Distributor for Nu.Q Discover link (PR Newswire)
Feb-09-26 05:20PM VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards link (PR Newswire)
Feb-04-26 08:45AM Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation link (PR Newswire)
Jan-30-26 08:50AM VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q Cancer Assays link (PR Newswire)
Jan-27-26 08:00AM Volition Announces Data to Support Use of Nu.Q NETs in New Indication link (PR Newswire)
Jan-20-26 08:25AM Volition Continues to Extend Access to Nu.Q Vet Cancer Test link (PR Newswire)
Jan-16-26 08:45AM Volition Sponsors Symposium at Veterinary Meeting and Expo link (PR Newswire)
Jan-08-26 09:15AM VolitionRx Secures $2.0 Million in Funding link (PR Newswire)
Jan-08-26 08:45AM VolitionRx Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats link (PR Newswire)
Dec-17-25 08:45AM Volition Issues Business Review 2025 link (PR Newswire)
Dec-11-25 09:00AM Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment link (PR Newswire)
Dec-08-25 09:00AM Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer link (PR Newswire)
Dec-04-25 09:00AM VolitionRx Limited Announces Inclusion of its Nu.Q NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis link (PR Newswire)
Nov-25-25 08:45AM VolitionRx Limited Announces the First Sale of the Nu.Q Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use link (PR Newswire)
Nov-14-25 04:01PM VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... link (GuruFocus.com)
Nov-13-25 05:41PM VolitionRX: Q3 Earnings Snapshot link (Associated Press Finance)
Nov-13-25 04:10PM VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update link (PR Newswire)
Nov-13-25 07:30AM VolitionRX Ltd (VNRX) Q3 2025: Everything You Need to Know Ahead of Earnings link (GuruFocus.com)
Nov-10-25 08:45AM VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update link (PR Newswire)
Oct-17-25 08:00AM Volition Donates Nu.Q Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs link (PR Newswire)
Oct-10-25 08:30AM VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants link (PR Newswire)
Oct-09-25 04:05PM VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants link (PR Newswire)
Oct-02-25 08:45AM Volition Sponsors Upcoming GenomeWeb Webinar link (PR Newswire)
Sep-29-25 09:30AM Volition Signs Co-Marketing and Services Agreement with Hologic link (PR Newswire)
Sep-09-25 08:45AM Volition Signs First Human Out Licensing Deal link (PR Newswire)
Aug-16-25 03:03AM VolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... link (GuruFocus.com)
Aug-14-25 05:06PM VolitionRX: Q2 Earnings Snapshot link (Associated Press Finance)
Aug-14-25 04:10PM VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update link (PR Newswire)
Aug-14-25 09:28AM VolitionRX Ltd (VNRX) Q2 2025 Earnings Report Preview: What To Expect link (GuruFocus.com)
Aug-08-25 08:30AM VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update link (PR Newswire)
Aug-04-25 04:01PM VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering link (PR Newswire)
Jul-16-25 08:00AM Nu.Q Discover Expands Global Adoption and Epigenetic Innovation link (PR Newswire)
Jul-08-25 08:00AM Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes link (PR Newswire)
Jun-12-25 08:30AM Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure link (PR Newswire)
Jun-04-25 09:00PM Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties link (PR Newswire)
May-19-25 08:30AM VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats link (PR Newswire)
May-17-25 03:02AM VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones link (GuruFocus.com)
May-15-25 06:12PM VolitionRX: Q1 Earnings Snapshot link (Associated Press Finance)
May-15-25 05:37PM VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update link (PR Newswire)
May-15-25 09:22AM VolitionRX Ltd (VNRX) Q1 2025 Earnings Report Preview: What To Look For link (GuruFocus.com)
May-12-25 08:30AM VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update link (PR Newswire)
May-07-25 08:30AM VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q NETs test adoption link (PR Newswire)
Apr-29-25 08:30AM VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets link (PR Newswire)
Apr-01-25 03:03AM VolitionRX Ltd (VNRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances link (GuruFocus.com)
Apr-01-25 12:31AM VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript link (Seeking Alpha)
Mar-31-25 04:05PM VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update link (PR Newswire)
Mar-28-25 08:00AM Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025 link (PR Newswire)
Mar-27-25 08:30AM Volition to Host Virtual Investor Event on Nu.Q Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025 link (PR Newswire)
Mar-26-25 08:00AM VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering link (PR Newswire)
Mar-25-25 09:30AM VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update link (PR Newswire)
Mar-21-25 08:30AM Volition's Nu.Q Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry link (PR Newswire)
Mar-20-25 08:30AM Volition Introduces Nu.Q Cancer Blood Test in New Industry Primer for Lung Cancer link (PR Newswire)
Mar-17-25 08:30AM Volition Proudly Sponsors the 44th ISICEM Congress link (PR Newswire)
Mar-13-25 08:30AM Volition Signs first ever Nu.Q Vet Cancer Test Automation Agreement with Fujifilm Vet Systems link (PR Newswire)
Mar-11-25 08:30AM Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q Lung Cancer Test link (PR Newswire)
Mar-04-25 08:30AM Volition's Nu.Q Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time link (PR Newswire)
Feb-28-25 08:30AM Volition Showcases Nu.Q Vet Cancer Test at the 97th WVC Annual Conference link (PR Newswire)
Feb-06-25 08:30AM Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis link (PR Newswire)
Feb-05-25 09:15AM Volition to Host Virtual Investor Event on Nu.Q NETs, "Casting a New Light on Sepsis Management", on February 14, 2025 link (PR Newswire)
Jan-30-25 08:30AM Large clinical study establishes Nu.Q NETs H3.1 as an independent predictor of 28-day mortality in sepsis link (PR Newswire)
Jan-08-25 08:30AM Volition Issues Business Review 2024 link (PR Newswire)
Dec-12-24 08:00AM VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants link (PR Newswire)
Dec-10-24 08:00AM Study shows Nu.Q Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening link (PR Newswire)
Dec-06-24 09:00AM VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering link (PR Newswire)
Nov-16-24 02:02AM VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... link (GuruFocus.com)